$3,699.00 – $4,299.00
Rubaca is a drug that has proven its effectiveness in the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, which is used to treat patients with malignant neoplasms. The drug prevents the growth of neoplasms and the spread of cancer cells throughout the body. On the pharmaceutical market, Rubaca is presented in the form of tablets with different dosages of the active substance (200, 250 and 300 mg).
Tablets based on the Rucaparib component for the treatment of patients with cancer are used mainly in the presence of a certain genetic marker – the abnormal BRCA gene. Also, the drug rubaca can be prescribed to patients with ovarian cancer who have undergone several courses of chemotherapy, but have not achieved the desired improvement. Rucaparib can also be useful in the treatment of prostate cancer if a man is diagnosed with an abnormal BRCA gene.
Active ingredient: Rucaparib
Prescription medicine
| Дозировка | 200 Mg, 250 Mg, 300 Mg |
|---|
